from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0438c/moeA2

LFCtreatmentdescriptionclass of inhibitor

-0.203

Amikacinug/mL Amikacintranslation

-0.292

Cap5-10ug/mL Capreomycintranslation

0.102

Rox10-50 ug/mL Roxithromycintranslation

0.080

SM2-5 ug/mL Streptomycintranslation

-0.123

Tet5-10 ug/mL Tetracyclinetranslation

0.712

Rif0.2-5ug/mL Rifampicintranscription

-0.189

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.161

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.347

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.096

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.183

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.491

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.634

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.918

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.689

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.089

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.609

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.194

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.183

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.306

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.081

KCN5-20 ug/mL Potassium cyaniderespiration

-0.442

NaN30.2-2 mM Sodium aziderespiration

0.654

Nigericin50 uM Nigericinrespiration

0.054

TRC10-150 ug/mL Triclosanrespiration

-1.370

TRZ10-25 ug/mL Thioridazinerespiration

-0.768

Valinomycin0.5-10 uM Valinomycinrespiration

0.302

ZnSO42 mM ZnSO4respiration

0.579

menadione6-10 ug/mL Menadionerespiration

-0.402

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.192

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.183

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.531

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.238

NRP_1Non-replicating persistence stage 1dosRassociated

-0.676

Amp0.2mg/mL AmpicillincellWall

0.256

Cephalexin20-100 ug/mL CephalexincellWall

0.459

Cerulenin0.32-5 ug/mL CerulenincellWall

0.439

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.250

EMB10-20 ug/mL EthambutolcellWall

-0.040

Eta12-40 ug/mL EthionamidecellWall

0.252

INH0.2-0.4 ug/mL IsoniazidcellWall

0.048

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.813

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.317

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.519

BZA0.12 mg/mL BenzamidearomaticAmides

0.647

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.298

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.321

H2O24 mM hydrogen peroxideDNAdamaging

0.225

Levo10 ug/mL LevofloxacinDNAdamaging

0.443

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.552

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.477

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.946

UVUV-irradiationDNAdamaging

-0.560

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.199

Antimycin12.5-50 ug/mL Antimycin A?

-0.350

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.646

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.082

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.686

PA8240.2-2 ug/mL PA-824?

-0.103

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.374

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.252

Verapamil50 uM Verapamil?

0.283

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.128

methoxatin10-20 ug/mL Methoxatin?